Crowd sourcing in drug discovery

被引：41

作者：

Lessl, Monika ^{[1
]}

Bryans, Justin S. ^{[2
]}

Richards, Duncan ^{[3
]}

Asadullah, Khusru ^{[1
]}

机构：

[1] Global Drug Discovery Bayer HealthCare Pharmaceut, D-13342 Berlin, Germany

[2] MRC Technol, Ctr Therapeut Discovery, London NW7 1AD, England

[3] GlaxoSmithKIine, Acad Discovery Performance Unit, Med Res Ctr, Stevenage SG1 2NY, Herts, England

来源：

NATURE REVIEWS DRUG DISCOVERY | 2011年 / 10卷 / 04期

基金：

英国医学研究理事会;

关键词：

D O I：

10.1038/nrd3412

中图分类号：

Q81 [生物工程学（生物技术）]; Q93 [微生物学];

学科分类号：

071005 [微生物学]; 090105 [作物生产系统与生态工程];

摘要：

Crowd sourcing is emerging as an open-innovation approach to promote collaboration and harness the complementary expertise of academic and industrial partners in the early stages of drug discovery. Here, we highlight examples of such initiatives and discuss key success factors.

引用

页码：241 / 242

页数：2

共 4 条

[1]

Bishop M., 2010, TOTAL EC IMPACT INNO

[2]

Howe J., 2008, Crowdsourcing: Why the power of the crowd is driving the future of business, V1

[3]

Grants4Targets-an innovative approach to translate ideas from basic research into novel drugs [J].

Lessl, Monika ;

Schoepe, Stefanie ;

Sommer, Anette ;

Schneider, Martin ;

Asadullah, Khusru .

DRUG DISCOVERY TODAY, 2011, 16 (7-8) :288-292

[4]

How to improve R&D productivity: the pharmaceutical industry's grand challenge [J].

Paul, Steven M. ;

Mytelka, Daniel S. ;

Dunwiddie, Christopher T. ;

Persinger, Charles C. ;

Munos, Bernard H. ;

Lindborg, Stacy R. ;

Schacht, Aaron L. .

NATURE REVIEWS DRUG DISCOVERY, 2010, 9 (03) :203-214

← 1 →